Li Q, Hirata Y, Piao S, Minami M
Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, 113-8602, Tokyo, Japan. li_qing/
Toxicology. 2000 Sep 7;150(1-3):179-89. doi: 10.1016/s0300-483x(00)00247-x.
We previously found that N,N-diethylaniline increased the frequency of sister chromatid exchange (SCE) of human lymphocytes to about five times that of the control value, and was as toxic as cyclophosphamide used as a positive control for SCE. To explore whether N,N-diethylaniline affects the function of lymphocytes, we evaluated its immunotoxicity using CBA/N mice. The mice were divided into four groups and received 0, 100, 200, or 400 mg/kg body weight of N,N-diethylaniline by subcutaneous injection. The following items were investigated on days 3 and 7 after injection: body weight, weight of spleen, number of splenocytes, natural killer (NK) and cytotoxic T lymphocyte (CTL) activities, and concanavalin A (Con A)- and lipopolysaccharide (LPS)-stimulated lymphocyte proliferation using splenocytes. The following splenocyte phenotypes were also quantified by flow cytometry: (1) B cells; (2) total T cells; (3) CD4(+) and CD8(+) T cells; (4) NK; (5) macrophages and (6) nucleated erythrocytes. The splenic NK and CTL activities in exposed groups significantly decreased compared to the control in a dose-dependent manner and lymphocytes from the 200 and 400 mg/kg groups showed significantly higher spontaneous proliferation. The weight of the spleen and number of splenocytes were significantly higher in exposed groups than in the control. N,N-Diethylaniline also increased the percentages of macrophages, nucleated erythrocytes and B cells in the spleen. On the other hand, N,N-diethylaniline did not affect LPS-stimulated B cell and Con A-stimulated T cell proliferation, or the percentages of NK, total T, and CD4(+) and CD8(+) T cells in the spleen or the body weight of mice. The above findings indicated that N,N-diethylaniline selectively inhibited splenic NK and CTL activity and this inhibition was due to decreased NK and CTL functions, but not due to changes in the numbers of splenic NK and T cells.
我们之前发现,N,N - 二乙苯胺可使人类淋巴细胞的姐妹染色单体交换(SCE)频率增加至对照值的约五倍,并且其毒性与用作SCE阳性对照的环磷酰胺相当。为了探究N,N - 二乙苯胺是否会影响淋巴细胞的功能,我们使用CBA/N小鼠评估了其免疫毒性。将小鼠分为四组,通过皮下注射给予0、100、200或400mg/kg体重的N,N - 二乙苯胺。在注射后第3天和第7天对以下项目进行了研究:体重、脾脏重量、脾细胞数量、自然杀伤(NK)和细胞毒性T淋巴细胞(CTL)活性,以及使用脾细胞检测刀豆蛋白A(Con A)和脂多糖(LPS)刺激的淋巴细胞增殖。还通过流式细胞术对以下脾细胞表型进行了定量分析:(1)B细胞;(2)总T细胞;(3)CD4(+)和CD8(+)T细胞;(4)NK细胞;(5)巨噬细胞和(6)有核红细胞。与对照组相比,暴露组的脾脏NK和CTL活性以剂量依赖性方式显著降低,并且来自200和400mg/kg组的淋巴细胞显示出明显更高的自发增殖。暴露组的脾脏重量和脾细胞数量显著高于对照组。N,N - 二乙苯胺还增加了脾脏中巨噬细胞、有核红细胞和B细胞的百分比。另一方面,N,N - 二乙苯胺不影响LPS刺激的B细胞和Con A刺激的T细胞增殖,也不影响脾脏中NK、总T以及CD4(+)和CD8(+)T细胞的百分比或小鼠的体重。上述研究结果表明,N,N - 二乙苯胺选择性抑制脾脏NK和CTL活性,这种抑制是由于NK和CTL功能降低,而非脾脏NK和T细胞数量的变化所致。